Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer

Gastrointestinal Endoscopy

Volumn 69, Issue 7, 2009, Pages 1210-1217

  Keswani, Rajesh N ^a   Early, Dayna S ^a   Edmundowicz, Steven A ^a   Meyers, Bryan F ^a   Sharma, Akash ^a   Govindan, Ramaswamy ^a   Chen, Jiajing ^a   Kohlmeier, Cara ^a   Azar, Riad R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER STAGING; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; INTESTINE CANCER; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CARCINOMA, SQUAMOUS CELL; CROSS-SECTIONAL STUDIES; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES;

EID: 67349161778     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2008.08.016     Document Type: Article

References (23)

1. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
2. Gebski V., Burmeister B., Smithers B.M., et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8 (2007) 226-234
3. Kelsen D.P., Winter K.A., Gunderson L.L., et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 25 (2007) 3719-3725
4. Williams D.B., Sahai A.V., Aabakken L., et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 44 (1999) 720-726
5. Meyers B.F., Downey R.J., Decker P.A., et al. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg 133 (2007) 738-745
6. Greene F.L., Page D.L., Fleming I.D., et al. AJCC cancer staging manual. 6th ed. (2002), Springer, New York
7. Catalano M.F., Sivak Jr. M.V., Rice T., et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc 40 (1994) 442-446
8. Vazquez-Sequeiros E., Wiersema M.J., Clain J.E., et al. Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology 125 (2003) 1626-1635
9. Van Dam J., Rice T.W., Catalano M.F., et al. High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation. Cancer 71 (1993) 2910-2917
10. Jacobson B.C., Shami V.M., Faigel D.O., et al. Through-the-scope balloon dilation for endoscopic ultrasound staging of stenosing esophageal cancer. Dig Dis Sci 52 (2007) 817-822
11. Pfau P.R., Ginsberg G.G., Lew R.J., et al. Esophageal dilation for endosonographic evaluation of malignant esophageal strictures is safe and effective. Am J Gastroenterol 95 (2000) 2813-2815
12. Rasanen J.V., Sihvo E.I., Knuuti M.J., et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 10 (2003) 954-960
13. Pfau P.R., Perlman S.B., Stanko P., et al. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography. Gastrointest Endosc 65 (2007) 377-384
14. Sandha G.S., Severin D., Postema E., et al. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS. Gastrointest Endosc 67 (2008) 402-409
15. Lowe V.J., Booya F., Fletcher J.G., et al. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol 7 (2005) 422-430
16. Lerut T., Flamen P., Ectors N., et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 232 (2000) 743-752
17. Morales C.P., Souza R.F., and Spechler S.J. Hallmarks of cancer progression in Barrett's oesophagus. Lancet 360 (2002) 1587-1589
18. Feith M., Stein H.J., and Siewert J.R. Pattern of lymphatic spread of Barrett's cancer. World J Surg 27 (2003) 1052-1057
19. Heeren P.A., Jager P.L., Bongaerts F., et al. Detection of distant metastases in esophageal cancer with (18)F-FDG PET. J Nucl Med 45 (2004) 980-987
20. McDonough P.B., Jones D.R., Shen K.R., et al. Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study. Am J Gastroenterol 103 (2008) 570-574
21. Maple J.T., Peifer K.J., Edmundowicz S.A., et al. The impact of endoscopic ultrasonography with fine needle aspiration (EUS-FNA) on esophageal cancer staging: a survey of thoracic surgeons and gastroenterologists. Dis Esophagus 21 (2008) 480-487
22. Vazquez-Sequeiros E., Norton I.D., Clain J.E., et al. Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. Gastrointest Endosc 53 (2001) 751-757
23. Chen V.K., and Eloubeidi M.A. Endoscopic ultrasound-guided fine needle aspiration is superior to lymph node echofeatures: a prospective evaluation of mediastinal and peri-intestinal lymphadenopathy. Am J Gastroenterol 99 (2004) 628-633